Status:
COMPLETED
Disease Course in an IBD Cohort in the Era of Biological Treatment
Lead Sponsor:
Hvidovre University Hospital
Collaborating Sponsors:
Ferring Pharmaceuticals
Merck Sharp & Dohme LLC
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
Brief Summary
The aim of the study is to do a 7-year follow-up of a consecutive inception cohort of 562 adults and children diagnosed and registered with inflammatory bowel disease in 2003-04 in order to evaluate t...
Eligibility Criteria
Inclusion
- All patients wil be followed up and diagnosis will be reassessed.
Exclusion
- Non-IBD (after reassessing diagnosis)
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT01468090
Start Date
October 1 2011
End Date
June 1 2014
Last Update
September 16 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hvidovre Hospital, Gastroenheden 360
Hvidovre, Denmark, 2650
2
Hvidovre hospital
Hvidovre, Denmark, 2650